202 related articles for article (PubMed ID: 22424435)
21. Systemic lupus erythematosus: predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: multivariate analyses and identification of risk factors.
Calvo-Alen J; Alarcon GS; Burgard SL; Burst N; Bartolucci AA; Williams HJ
J Rheumatol; 1996 Mar; 23(3):469-75. PubMed ID: 8832985
[TBL] [Abstract][Full Text] [Related]
22. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
[TBL] [Abstract][Full Text] [Related]
23. Information on diagnosis and management of systemic lupus erythematosus derived from the routine measurement of 8 nuclear autoantibodies.
Ignat GP; Rat AC; Sychra JJ; Vo J; Varga J; Teodorescu M
J Rheumatol; 2003 Aug; 30(8):1761-9. PubMed ID: 12913932
[TBL] [Abstract][Full Text] [Related]
24. Expression of T-bet, a type 1 T-helper cell transcription factor, in the urinary sediment of lupus patients predicts disease flare.
Chan RW; Lai FM; Li EK; Tam LS; Chow KM; Li PK; Szeto CC
Rheumatology (Oxford); 2007 Jan; 46(1):44-8. PubMed ID: 16754628
[TBL] [Abstract][Full Text] [Related]
25. Emerging Molecular Markers Towards Potential Diagnostic Panels for Lupus.
Tan G; Baby B; Zhou Y; Wu T
Front Immunol; 2021; 12():808839. PubMed ID: 35095896
[TBL] [Abstract][Full Text] [Related]
26. Monitoring of urinary messenger RNA levels for the prediction of flare in systemic lupus erythematosus.
Szeto CC; Tam LS; Kwan BC; Lai KB; Wang G; Li EK; Chow KM; Lai FM; Li PK
Clin Chim Acta; 2012 Feb; 413(3-4):448-55. PubMed ID: 22120729
[TBL] [Abstract][Full Text] [Related]
27. Routine immunologic tests in systemic lupus erythematosus: is there a need for more studies?
Esdaile JM; Joseph L; Abrahamowicz M; Li Y; Danoff D; Clarke AE
J Rheumatol; 1996 Nov; 23(11):1891-6. PubMed ID: 8923362
[TBL] [Abstract][Full Text] [Related]
28. Frequency and determinants of flare and persistently active disease in systemic lupus erythematosus.
Nikpour M; Urowitz MB; Ibañez D; Gladman DD
Arthritis Rheum; 2009 Sep; 61(9):1152-8. PubMed ID: 19714602
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of erythrocyte-bound C4d as a biomarker to predict disease activity in patients with systemic lupus erythematosus.
Yang DH; Chang DM; Lai JH; Lin FH; Chen CH
Rheumatology (Oxford); 2009 Sep; 48(9):1083-7. PubMed ID: 19553377
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome.
Lozovoy MA; Simão AN; Hohmann MS; Simão TN; Barbosa DS; Morimoto HK; Reiche EM; Cecchini R; Dichi I
Lupus; 2011 Nov; 20(13):1356-64. PubMed ID: 21868433
[TBL] [Abstract][Full Text] [Related]
32. Clinical disease activity and flare in SLE: Current concepts and novel biomarkers.
Thanou A; Jupe E; Purushothaman M; Niewold TB; Munroe ME
J Autoimmun; 2021 May; 119():102615. PubMed ID: 33631651
[TBL] [Abstract][Full Text] [Related]
33. Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus.
Utz PJ
Lupus; 2004; 13(5):304-11. PubMed ID: 15230283
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients.
Yang L; Tao J; Tang X; Wang Y; He X; Xu G; Ren Y; Tu Y
J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):95-101. PubMed ID: 21851424
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
Grönhagen CM; Fored CM; Granath F; Nyberg F
Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
[TBL] [Abstract][Full Text] [Related]
36. [Systemic lupus erythematosus and pregnancy. Clinical aspects, serology and management].
Runge HM; Röther E; Kerl J; DuBois A; Quaas L; Hillemanns HG
Geburtshilfe Frauenheilkd; 1990 Jul; 50(7):560-8. PubMed ID: 2391023
[TBL] [Abstract][Full Text] [Related]
37. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
[TBL] [Abstract][Full Text] [Related]
38. Markers of inflammation and atherosclerosis in Egyptian patients with systemic lupus erythematosus.
Sabry AA; Elbasyouni SR; Kalil AM; Abdel-Rahim M; Mohsen T; Sleem A
Nephrology (Carlton); 2006 Aug; 11(4):329-35. PubMed ID: 16889573
[TBL] [Abstract][Full Text] [Related]
39. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.
Bertsias G; Ioannidis JP; Boletis J; Bombardieri S; Cervera R; Dostal C; Font J; Gilboe IM; Houssiau F; Huizinga T; Isenberg D; Kallenberg CG; Khamashta M; Piette JC; Schneider M; Smolen J; Sturfelt G; Tincani A; van Vollenhoven R; Gordon C; Boumpas DT;
Ann Rheum Dis; 2008 Feb; 67(2):195-205. PubMed ID: 17504841
[TBL] [Abstract][Full Text] [Related]
40. Biomarkers of sepsis.
Marshall JC; Reinhart K;
Crit Care Med; 2009 Jul; 37(7):2290-8. PubMed ID: 19487943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
